Literature DB >> 98790

Acute psychologic and neuroendocrine effects of dextroamphetamine and methylphenidate.

W A Brown, D P Corriveau, M H Ebert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 98790     DOI： 10.1007/bf00426906

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  17 in total

Review 1.  Neuropharmacologic control of neuroendocrine function in man.

Authors:  L A Frohman; M E Stachura
Journal:  Metabolism       Date:  1975-02       Impact factor: 8.694

2.  Psychologic and neuroendocrine response to methylphenidate.

Authors:  W A Brown
Journal:  Arch Gen Psychiatry       Date:  1977-09

3.  L-dopa, dopamine, and hypomania.

Authors:  D L Murphy; F K Goodwin; H K Brodie; W E Bunney
Journal:  Am J Psychiatry       Date:  1973-01       Impact factor: 18.112

4.  A sensitive double antibody radioimmunoassay for human growth hormone (HGH): levels of serum HGH following rapid tolbutamide infusion.

Authors:  G Boden; J S Soeldner
Journal:  Diabetologia       Date:  1967-10       Impact factor: 10.122

5.  The effect of the stimulant drugs, dextroamphetamine and methylphenidate, on secretion of growth hormone in hyperactive children.

Authors:  D Aarskog; F O Fevang; H Klove; K F Stoa; T Thorsen
Journal:  J Pediatr       Date:  1977-01       Impact factor: 4.406

6.  The involvement of dopaminergic systems with the stereotyped behaviour patterns induced by methylphenidate.

Authors:  B Costall; R J Naylor
Journal:  J Pharm Pharmacol       Date:  1974-01       Impact factor: 3.765

Review 7.  Psychiatric side effects of levodopa in man.

Authors:  F K Goodwin
Journal:  JAMA       Date:  1971-12-27       Impact factor: 56.272

8.  Growth hormone response to D-amphetamine in normal controls and in depressive patients.

Authors:  G Langer; G Heinze; B Reim; N Matussek
Journal:  Neurosci Lett       Date:  1975-09       Impact factor: 3.046

9.  Methylphenidate, dextroamphetamine, and levamfetamine. Effects on schizophrenic symptoms.

Authors:  D S Janowsky; J M Davis
Journal:  Arch Gen Psychiatry       Date:  1976-03

10.  Comparative effects of d-amphetamine, l-amphetamine, and methylphenidate on mood in man.

Authors:  R C Smith; J M Davis
Journal:  Psychopharmacology (Berl)       Date:  1977-06-06       Impact factor: 4.530
View more
  8 in total

Review 1.  Genetic factors modulating the response to stimulant drugs in humans.

Authors:  Amy B Hart; Harriet de Wit; Abraham A Palmer
Journal:  Curr Top Behav Neurosci       Date:  2012

2.  Variability in paralimbic dopamine signaling correlates with subjective responses to d-amphetamine.

Authors:  Christopher T Smith; Linh C Dang; Ronald L Cowan; Robert M Kessler; David H Zald
Journal:  Neuropharmacology       Date:  2016-05-10       Impact factor: 5.250

3.  Evidence for ACTH-unrelated mechanisms in the regulation of cortisol secretion in man.

Authors:  H L Fehm; R Holl; K Steiner; E Klein; K H Voigt
Journal:  Klin Wochenschr       Date:  1984-01-02

4.  d-Amphetamine raises cortisol levels in schizophrenic patients with and without chronic naltrexone pretreatment.

Authors:  D P van Kammen; S C Schulz
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

5.  D-amphetamine in obsessive-compulsive disorder.

Authors:  T R Insel; J A Hamilton; L B Guttmacher; D L Murphy
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

6.  Provocative tests with psychostimulant drugs in schizophrenia.

Authors:  J A Lieberman; J M Kane; J Alvir
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

7.  Individual differences in timing of peak positive subjective responses to d-amphetamine: Relationship to pharmacokinetics and physiology.

Authors:  Christopher T Smith; Jessica Weafer; Ronald L Cowan; Robert M Kessler; Abraham A Palmer; Harriet de Wit; David H Zald
Journal:  J Psychopharmacol       Date:  2016-02-15       Impact factor: 4.153

8.  Subjective responses to amphetamine in young adults with previous mood elevation experiences.

Authors:  Scott T Schepers; David L Arndt; Robert D Rogers; Donald Hedeker; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2019-06-17       Impact factor: 4.530
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.